| Profile | GDS4177 / 201722_s_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 1080.79 | 95 |
| GSM603099 | KU-812 non-treated | 1509.54 | 97 |
| GSM603098 | KCL-22 Imatinib-treated | 1998.28 | 98 |
| GSM603097 | KCL-22 non-treated | 1731.53 | 97 |
| GSM603102 | JURL-MK1 Imatinib-treated | 699.78 | 93 |
| GSM603101 | JURL-MK1 non-treated | 1180.04 | 96 |